| scholarly article | Q13442814 |
| P50 | author | Ulisses Braga Neto | Q26702552 |
| Marli Tenorio Cordeiro | Q29460141 | ||
| Ernesto T A Marques | Q62676198 | ||
| P2093 | author name string | Andréa Barbosa de Melo | |
| Giovani Rota Bertani | |||
| Laura Helena Vega Gonzales Gil | |||
| Eduardo M Freese de Carvalho | |||
| Maria Cecília F Magalhães | |||
| Maria da Paz C da Silva | |||
| P2860 | cites work | Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses | Q24696032 |
| Endemic emergence of yellow fever in the Ivory Coast: the place of anti-yellow fever IgM detection in the strategy of surveillance | Q27469199 | ||
| Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus | Q27485366 | ||
| Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination | Q27487839 | ||
| Yellow Fever Vaccine | Q27487915 | ||
| Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization | Q27488408 | ||
| Anamnestic immune response to dengue and decreased severity of yellow fever | Q27491296 | ||
| Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination | Q33613475 | ||
| Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases | Q34516458 | ||
| Yellow fever: an update | Q34547781 | ||
| Emergent arboviruses in Brazil | Q34637517 | ||
| Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? | Q34986346 | ||
| Serodiagnosis of flaviviral infections and vaccinations in humans | Q35625007 | ||
| Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease | Q35952794 | ||
| New developments in flavivirus vaccines with special attention to yellow fever | Q36251662 | ||
| Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil | Q37358125 | ||
| Dengue: twenty-five years since reemergence in Brazil | Q37415349 | ||
| Risk assessment of yellow fever urbanization in Rio de Janeiro, Brazil | Q38949537 | ||
| Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil | Q39595868 | ||
| Aedes aegypti in Brazil: genetically differentiated populations with high susceptibility to dengue and yellow fever viruses | Q39672750 | ||
| Short report: Incidence of yellow fever vaccine-associated neurotropic disease | Q40372050 | ||
| Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue | Q40392539 | ||
| Dengue-yellow fever sera cross-reactivity; challenges for diagnosis | Q40403788 | ||
| Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. | Q40429365 | ||
| Characterization of a dengue patient cohort in Recife, Brazil. | Q40430488 | ||
| Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. | Q40465536 | ||
| Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos | Q40492226 | ||
| The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil | Q40495879 | ||
| Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial. | Q40512856 | ||
| Large genetic differentiation and low variation in vector competence for dengue and yellow fever viruses of Aedes albopictus from Brazil, the United States, and the Cayman Islands | Q40551707 | ||
| MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination | Q40557198 | ||
| Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. | Q40575888 | ||
| Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. | Q40627603 | ||
| Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. | Q40691602 | ||
| Use of MAC-ELISA for evaluation of yellow fever vaccination | Q40730193 | ||
| An ELISA procedure for the diagnosis of dengue infections | Q40747847 | ||
| Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay | Q40800338 | ||
| Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans | Q40927666 | ||
| Overcoming health inequity: potential benefits of a patient-centered open-source public health infostructure | Q42647745 | ||
| Genetic variability among yellow fever virus 17D substrains | Q42989276 | ||
| Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection | Q42990104 | ||
| Neurologic disorders after measles-mumps-rubella vaccination | Q50346278 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Brazil | Q155 |
| yellow fever | Q154874 | ||
| yellow fever virus | Q836749 | ||
| yellow fever vaccine | Q8051876 | ||
| P304 | page(s) | 739-747 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil | |
| P478 | volume | 85 |
| Q37521917 | 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study |
| Q39032355 | A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination |
| Q36487320 | Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients |
| Q37625156 | C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. |
| Q35886539 | Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals |
| Q36450167 | Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination |
| Q40198081 | Duration of post-vaccination immunity against yellow fever in adults |
| Q102387839 | Duration of seropositivity following yellow fever vaccination in U.S. military service members |
| Q37166091 | Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. |
| Q35210878 | Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues. |
| Q35018972 | Identification of conserved and HLA promiscuous DENV3 T-cell epitopes |
| Q41928914 | Lineage-Specific Real-Time RT-PCR for Yellow Fever Virus Outbreak Surveillance, Brazil |
| Q28954598 | Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day |
| Q100503905 | Modeling the potential of wAu-Wolbachia strain invasion in mosquitoes to control Aedes-borne arboviral infections |
| Q90215874 | Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting |
| Q57808582 | Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers |
| Q39706701 | Questions regarding the safety and duration of immunity following live yellow fever vaccination |
| Q39200155 | Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil |
| Q28485408 | T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs |
| Q46239950 | The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences |
| Q59356551 | Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat |
Search more.